ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682995; 2) Community: the network communities that were significantly associated with the response to NSC 682995; 3) Molecule: the relationships between components within communities and NSC 682995; 4) MDR: the compounds that were significantly associated with the NSC 682995.

NSC Compound Enrichment Correlation
NSC 87500 Solacongestidine 0.0187770954927753 0.15163134
NSC 106995 U 24792 0.0242256744004388 -0.015473416
NSC 130876 Null 0.0242256744004388 0.15365545
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0242256744004388 0.75166421
NSC 735181 (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl 4-methylpiperazine-1-carbodithioate 0.0242256744004388 0.63450393
NSC 732826 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-methoxybenzene 0.0247898374452139 0.33348602
NSC 743688 Null 0.0247898374452139 0.18018452
NSC 251668 OVATIFOLIN ACETATE 0.024789837445214 0.72887259
NSC 323241 3-Azabicyclo[3.2.2]nonane-3-carboselenoic acid, [1-(2-pyridinyl)ethylidene]hydrazide 0.024789837445214 0.36822555
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.024789837445214 -0.19844945
Total:123  Current:65    [First] [Prev] [Next] [Last]